We are excited to share the news of our newly established distribution partnership with Methapharm for the ๐—ฆ๐—ฐ๐—น๐—ฒ๐—ฟ๐—ผ๐—ฆ๐—ฎ๐—ณ๐—ฒโ„ข FDA-Approved platform!

Methapharm stands out as the perfect collaborator for distributing ๐—ฆ๐—ฐ๐—น๐—ฒ๐—ฟ๐—ผ๐—ฆ๐—ฎ๐—ณ๐—ฒโ„ข, leveraging their profound expertise in varicose veins and well-established connections with key stakeholders and physicians in the US.

The partnership is strengthened by the remarkable synergy between our two companies, both dedicated to the effective, Non-Thermal, Non-Tumescent (NT-NT) treatment and management of varicosities in superficial veins.



For the full press releases:

https://venousnews.com/vvt-medical-and-methapharm-sign-a-distribution-agreement-for-the-marketing-of-sclerosafe-in-the-usa/

https://evtoday.com/news/vvt-medicals-sclerosafe-to-be-marketed-by-methapharm-in-the-united-states